Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 20 | 2022 | 799 | 4.460 |
Why?
|
| Heart Defects, Congenital | 26 | 2022 | 1795 | 3.790 |
Why?
|
| Cardiopulmonary Bypass | 14 | 2021 | 391 | 3.500 |
Why?
|
| Cardiac Surgical Procedures | 17 | 2024 | 1159 | 2.530 |
Why?
|
| Pediatrics | 12 | 2022 | 1185 | 2.420 |
Why?
|
| Hemodynamics | 14 | 2023 | 949 | 2.210 |
Why?
|
| Critical Illness | 11 | 2023 | 739 | 2.070 |
Why?
|
| Monitoring, Physiologic | 11 | 2022 | 522 | 1.750 |
Why?
|
| Oxygen | 8 | 2021 | 792 | 1.620 |
Why?
|
| Intensive Care Units, Pediatric | 9 | 2021 | 474 | 1.590 |
Why?
|
| Shock, Cardiogenic | 2 | 2023 | 193 | 1.570 |
Why?
|
| Cardiology | 4 | 2017 | 510 | 1.530 |
Why?
|
| Oximetry | 7 | 2021 | 190 | 1.430 |
Why?
|
| Spectroscopy, Near-Infrared | 4 | 2021 | 173 | 1.400 |
Why?
|
| Heart Failure | 8 | 2016 | 2332 | 1.390 |
Why?
|
| Capnography | 2 | 2020 | 14 | 1.310 |
Why?
|
| Cardiovascular System | 2 | 2023 | 140 | 1.280 |
Why?
|
| Heart Diseases | 4 | 2019 | 723 | 1.150 |
Why?
|
| Sepsis | 2 | 2023 | 686 | 1.140 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2017 | 327 | 0.970 |
Why?
|
| Nitric Oxide | 5 | 2019 | 659 | 0.970 |
Why?
|
| Child | 46 | 2022 | 30517 | 0.970 |
Why?
|
| Cardiac Output | 7 | 2022 | 194 | 0.960 |
Why?
|
| Arginine Vasopressin | 1 | 2023 | 66 | 0.890 |
Why?
|
| Physicians | 3 | 2022 | 852 | 0.830 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2014 | 635 | 0.820 |
Why?
|
| Blood Pressure | 6 | 2022 | 1570 | 0.800 |
Why?
|
| Hypertension, Pulmonary | 5 | 2019 | 464 | 0.790 |
Why?
|
| Heart | 4 | 2023 | 1195 | 0.780 |
Why?
|
| Tetralogy of Fallot | 3 | 2012 | 164 | 0.780 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2021 | 169 | 0.770 |
Why?
|
| Cerebrovascular Circulation | 3 | 2021 | 513 | 0.770 |
Why?
|
| Certification | 2 | 2019 | 107 | 0.760 |
Why?
|
| Fontan Procedure | 1 | 2023 | 181 | 0.750 |
Why?
|
| Heart-Assist Devices | 3 | 2022 | 1044 | 0.720 |
Why?
|
| Natriuretic Agents | 2 | 2017 | 32 | 0.710 |
Why?
|
| Acute Kidney Injury | 3 | 2017 | 760 | 0.690 |
Why?
|
| Infant, Newborn | 17 | 2022 | 8694 | 0.680 |
Why?
|
| Humans | 84 | 2024 | 270631 | 0.670 |
Why?
|
| Triiodothyronine | 1 | 2019 | 84 | 0.660 |
Why?
|
| Infant | 24 | 2020 | 13982 | 0.650 |
Why?
|
| Inflammation | 2 | 2020 | 2517 | 0.640 |
Why?
|
| Internationality | 1 | 2019 | 205 | 0.630 |
Why?
|
| Respiratory Tract Diseases | 2 | 2016 | 111 | 0.600 |
Why?
|
| Postoperative Complications | 8 | 2020 | 5672 | 0.600 |
Why?
|
| Lung | 2 | 2020 | 3299 | 0.590 |
Why?
|
| Hypothyroidism | 1 | 2019 | 207 | 0.570 |
Why?
|
| Curriculum | 2 | 2022 | 916 | 0.570 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 702 | 0.570 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 565 | 0.570 |
Why?
|
| Vasopressins | 3 | 2021 | 62 | 0.560 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 214 | 0.560 |
Why?
|
| Hospital Mortality | 5 | 2021 | 1232 | 0.550 |
Why?
|
| Carbon Dioxide | 2 | 2020 | 327 | 0.550 |
Why?
|
| Postoperative Care | 5 | 2020 | 728 | 0.540 |
Why?
|
| Respiratory System | 1 | 2016 | 129 | 0.510 |
Why?
|
| Shock | 1 | 2016 | 93 | 0.500 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 151 | 0.500 |
Why?
|
| Immune System Diseases | 1 | 2015 | 65 | 0.490 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 4374 | 0.480 |
Why?
|
| Immunomodulation | 1 | 2016 | 255 | 0.480 |
Why?
|
| Clinical Competence | 2 | 2019 | 1323 | 0.460 |
Why?
|
| Child, Preschool | 18 | 2020 | 17028 | 0.460 |
Why?
|
| Child Abuse | 1 | 2017 | 208 | 0.460 |
Why?
|
| Ventilator Weaning | 2 | 2010 | 33 | 0.440 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2013 | 49 | 0.440 |
Why?
|
| Congresses as Topic | 1 | 2015 | 298 | 0.440 |
Why?
|
| Societies, Medical | 5 | 2015 | 1320 | 0.430 |
Why?
|
| Education, Medical | 1 | 2017 | 344 | 0.430 |
Why?
|
| Shock, Septic | 1 | 2015 | 188 | 0.430 |
Why?
|
| Vascular Resistance | 2 | 2020 | 213 | 0.420 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 411 | 0.410 |
Why?
|
| Cardiovascular Diseases | 3 | 2016 | 2211 | 0.410 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 417 | 0.410 |
Why?
|
| Vancomycin | 1 | 2014 | 290 | 0.400 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 285 | 0.390 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2011 | 17 | 0.390 |
Why?
|
| Airway Extubation | 1 | 2012 | 74 | 0.380 |
Why?
|
| Cardiac Output, Low | 1 | 2010 | 76 | 0.350 |
Why?
|
| Length of Stay | 6 | 2021 | 2004 | 0.350 |
Why?
|
| Positive-Pressure Respiration | 1 | 2010 | 123 | 0.350 |
Why?
|
| Pituitary-Adrenal System | 1 | 2010 | 97 | 0.340 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 127 | 0.330 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 47 | 0.330 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2010 | 81 | 0.330 |
Why?
|
| Consensus | 2 | 2011 | 1104 | 0.330 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 271 | 0.330 |
Why?
|
| Coronary Care Units | 4 | 2020 | 37 | 0.320 |
Why?
|
| Intensive Care Units | 6 | 2020 | 735 | 0.320 |
Why?
|
| Diuretics | 3 | 2019 | 171 | 0.310 |
Why?
|
| Brain | 2 | 2012 | 4212 | 0.300 |
Why?
|
| Respiration, Artificial | 6 | 2019 | 580 | 0.300 |
Why?
|
| Peritoneal Dialysis | 2 | 2020 | 140 | 0.290 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 1034 | 0.290 |
Why?
|
| Postoperative Period | 4 | 2019 | 667 | 0.290 |
Why?
|
| Steroids | 1 | 2009 | 371 | 0.280 |
Why?
|
| Arteries | 2 | 2019 | 290 | 0.270 |
Why?
|
| Infusions, Intravenous | 3 | 2020 | 1437 | 0.270 |
Why?
|
| Fluid Therapy | 2 | 2022 | 192 | 0.270 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2021 | 183 | 0.270 |
Why?
|
| Hospitalization | 5 | 2021 | 2168 | 0.260 |
Why?
|
| Administration, Inhalation | 3 | 2019 | 300 | 0.240 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2009 | 345 | 0.240 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2024 | 451 | 0.240 |
Why?
|
| Retrospective Studies | 15 | 2022 | 39811 | 0.240 |
Why?
|
| Treatment Outcome | 12 | 2024 | 33722 | 0.230 |
Why?
|
| Creatinine | 2 | 2017 | 529 | 0.220 |
Why?
|
| Heart Rate | 3 | 2020 | 751 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 2650 | 0.220 |
Why?
|
| Respiration | 3 | 2016 | 465 | 0.210 |
Why?
|
| Hemodynamic Monitoring | 1 | 2022 | 12 | 0.210 |
Why?
|
| Cause of Death | 2 | 2019 | 780 | 0.210 |
Why?
|
| Dexamethasone | 3 | 2005 | 1507 | 0.200 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 306 | 0.200 |
Why?
|
| Acute Disease | 3 | 2016 | 2495 | 0.200 |
Why?
|
| Mediastinum | 1 | 2023 | 276 | 0.200 |
Why?
|
| Water | 1 | 2023 | 388 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 3176 | 0.190 |
Why?
|
| Vena Cava, Superior | 1 | 2021 | 78 | 0.190 |
Why?
|
| Prospective Studies | 7 | 2020 | 13412 | 0.190 |
Why?
|
| Nicardipine | 1 | 2020 | 17 | 0.180 |
Why?
|
| Tidal Volume | 1 | 2020 | 58 | 0.180 |
Why?
|
| Nitroprusside | 1 | 2020 | 55 | 0.180 |
Why?
|
| Sodium Bicarbonate | 1 | 2020 | 56 | 0.170 |
Why?
|
| Male | 22 | 2020 | 128316 | 0.170 |
Why?
|
| Biological Transport | 2 | 2011 | 627 | 0.170 |
Why?
|
| Vasoconstrictor Agents | 1 | 2020 | 166 | 0.170 |
Why?
|
| Hypotension | 1 | 2021 | 231 | 0.170 |
Why?
|
| Time Factors | 6 | 2019 | 13017 | 0.170 |
Why?
|
| Heart Septal Defects | 1 | 2019 | 49 | 0.170 |
Why?
|
| Noonan Syndrome | 1 | 2019 | 29 | 0.170 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 552 | 0.170 |
Why?
|
| Acidosis | 1 | 2020 | 117 | 0.160 |
Why?
|
| Female | 22 | 2020 | 148865 | 0.160 |
Why?
|
| United States | 6 | 2022 | 15834 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 663 | 0.150 |
Why?
|
| Case-Control Studies | 3 | 2019 | 6238 | 0.150 |
Why?
|
| Arginine | 1 | 2021 | 508 | 0.150 |
Why?
|
| Heart Valve Diseases | 1 | 2019 | 183 | 0.150 |
Why?
|
| Age Factors | 2 | 2019 | 5464 | 0.140 |
Why?
|
| Bronchodilator Agents | 1 | 2019 | 225 | 0.140 |
Why?
|
| Oliguria | 1 | 2017 | 20 | 0.140 |
Why?
|
| Water-Electrolyte Balance | 1 | 2017 | 97 | 0.140 |
Why?
|
| Nurses | 1 | 2017 | 85 | 0.140 |
Why?
|
| Chlorothiazide | 1 | 2016 | 12 | 0.140 |
Why?
|
| Respiratory Insufficiency | 2 | 2012 | 344 | 0.140 |
Why?
|
| Nephrons | 1 | 2016 | 42 | 0.140 |
Why?
|
| Diuresis | 1 | 2016 | 63 | 0.140 |
Why?
|
| Risk Assessment | 5 | 2021 | 6766 | 0.140 |
Why?
|
| Veins | 1 | 2017 | 165 | 0.130 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2016 | 78 | 0.130 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2015 | 15 | 0.130 |
Why?
|
| Ventricular Pressure | 1 | 2016 | 44 | 0.130 |
Why?
|
| Alprostadil | 1 | 2015 | 37 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2019 | 684 | 0.130 |
Why?
|
| Specialization | 1 | 2016 | 127 | 0.120 |
Why?
|
| Reoperation | 1 | 2019 | 1391 | 0.120 |
Why?
|
| Inpatients | 1 | 2020 | 686 | 0.120 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 142 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2017 | 398 | 0.120 |
Why?
|
| Weight Gain | 1 | 2017 | 472 | 0.120 |
Why?
|
| Heart Ventricles | 1 | 2019 | 848 | 0.120 |
Why?
|
| Premedication | 2 | 2005 | 133 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 230 | 0.110 |
Why?
|
| Adolescent | 6 | 2021 | 32719 | 0.110 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 156 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2014 | 416 | 0.110 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 562 | 0.110 |
Why?
|
| Publications | 1 | 2013 | 54 | 0.110 |
Why?
|
| Risk Factors | 4 | 2020 | 17875 | 0.110 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2012 | 4 | 0.100 |
Why?
|
| Global Health | 1 | 2017 | 685 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1245 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 5070 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 248 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 317 | 0.100 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 292 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 1312 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 3529 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2016 | 821 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2016 | 1825 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2014 | 341 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2020 | 2250 | 0.090 |
Why?
|
| Hypertension | 1 | 2020 | 1589 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 4326 | 0.090 |
Why?
|
| California | 1 | 2010 | 212 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 4491 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2016 | 755 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 460 | 0.090 |
Why?
|
| Logistic Models | 2 | 2014 | 3447 | 0.090 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 175 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 104 | 0.080 |
Why?
|
| Calcium | 1 | 2016 | 1588 | 0.080 |
Why?
|
| Reperfusion | 1 | 2009 | 25 | 0.080 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2009 | 45 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2014 | 798 | 0.080 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2014 | 625 | 0.080 |
Why?
|
| Texas | 3 | 2015 | 6436 | 0.080 |
Why?
|
| Pressure | 1 | 2009 | 189 | 0.080 |
Why?
|
| Registries | 2 | 2019 | 2209 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 15204 | 0.080 |
Why?
|
| Animals | 4 | 2024 | 62031 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 2119 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2019 | 9290 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 192 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2008 | 255 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 400 | 0.070 |
Why?
|
| Biomarkers | 2 | 2014 | 5060 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2904 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2005 | 198 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1416 | 0.060 |
Why?
|
| Cannabinoids | 1 | 2024 | 43 | 0.060 |
Why?
|
| Incidence | 1 | 2014 | 5821 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 595 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 1097 | 0.060 |
Why?
|
| Central Venous Pressure | 1 | 2022 | 27 | 0.050 |
Why?
|
| Troponin I | 1 | 2003 | 130 | 0.050 |
Why?
|
| Phentolamine | 1 | 2021 | 28 | 0.050 |
Why?
|
| Calcium Chloride | 1 | 2021 | 25 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2005 | 618 | 0.050 |
Why?
|
| Morbidity | 2 | 2015 | 400 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 2394 | 0.050 |
Why?
|
| Complement C3a | 1 | 2000 | 21 | 0.040 |
Why?
|
| Japan | 1 | 2020 | 236 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2020 | 122 | 0.040 |
Why?
|
| Cytokines | 1 | 2009 | 2826 | 0.040 |
Why?
|
| Body Temperature | 1 | 2000 | 163 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2020 | 106 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 606 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 243 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 310 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2000 | 735 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2003 | 2588 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2020 | 544 | 0.040 |
Why?
|
| Risk Adjustment | 1 | 2017 | 74 | 0.040 |
Why?
|
| Furosemide | 1 | 2016 | 40 | 0.040 |
Why?
|
| Down Syndrome | 1 | 2019 | 227 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 521 | 0.030 |
Why?
|
| Birthing Centers | 1 | 2015 | 10 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 591 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2000 | 1051 | 0.030 |
Why?
|
| Neutrophils | 1 | 2000 | 873 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 261 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 1585 | 0.030 |
Why?
|
| Bradycardia | 1 | 2014 | 73 | 0.030 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2013 | 16 | 0.030 |
Why?
|
| Prognosis | 1 | 2011 | 22473 | 0.030 |
Why?
|
| Missouri | 1 | 2012 | 41 | 0.030 |
Why?
|
| Gases | 1 | 2012 | 39 | 0.030 |
Why?
|
| Pregnancy | 2 | 2017 | 8117 | 0.030 |
Why?
|
| Troponin | 1 | 2012 | 87 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2014 | 220 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 417 | 0.020 |
Why?
|
| Catheterization | 1 | 2014 | 417 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 2344 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2017 | 2238 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 1609 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 1986 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2014 | 572 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 775 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 1933 | 0.020 |
Why?
|
| Adult | 3 | 2020 | 81946 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 2846 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 4875 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2005 | 418 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2005 | 447 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 985 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 6853 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 2319 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 22201 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 73338 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 90294 | 0.010 |
Why?
|